First Trust Capital Management L.P. 收购了医疗科技收购公司644,740股股份（纳斯达克股票代码：MTAC）

First Trust Capital Management L.P. grew its holdings in MedTech Acquisition Co. (NASDAQ:MTAC – Get Rating) by 937.2% in the 3rd quarter, Holdings Channel reports. The fund owned 713,532 shares of the company's stock after purchasing an additional 644,740 shares during the quarter. First Trust Capital Management L.P.'s holdings in MedTech Acquisition were worth $7,085,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of MTAC. Glazer Capital LLC boosted its position in MedTech Acquisition by 6.0% during the third quarter. Glazer Capital LLC now owns 963,032 shares of the company's stock valued at $9,563,000 after purchasing an additional 54,142 shares during the last quarter. Bank of Montreal Can boosted its holdings in shares of MedTech Acquisition by 0.6% in the 3rd quarter. Bank of Montreal Can now owns 781,803 shares of the company's stock valued at $7,779,000 after purchasing an additional 4,782 shares in the last quarter. RPO LLC boosted its holdings in shares of MedTech Acquisition by 37.2% in the 3rd quarter. RPO LLC now owns 699,600 shares of the company's stock valued at $6,947,000 after purchasing an additional 189,708 shares in the last quarter. Verition Fund Management LLC boosted its holdings in shares of MedTech Acquisition by 8.4% in the 2nd quarter. Verition Fund Management LLC now owns 625,928 shares of the company's stock valued at $6,159,000 after purchasing an additional 48,546 shares in the last quarter. Finally, Mizuho Securities USA LLC acquired a new stake in shares of MedTech Acquisition during the 3rd quarter valued at $4,506,000. 74.91% of the stock is owned by institutional investors and hedge funds.

MedTech Acquisition Stock Performance

Shares of NASDAQ MTAC remained flat at $10.12 during mid-day trading on Tuesday. MedTech Acquisition Co. has a 1-year low of $8.99 and a 1-year high of $10.68. The company has a 50 day simple moving average of $10.10 and a 200-day simple moving average of $10.02.

MedTech Acquisition Profile

(Get Rating)

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.

See Also

• Get a free copy of the StockNews.com research report on MedTech Acquisition (MTAC)
• Will Q4 Results Send Zoom Video Stock Higher?
• Is Amazon a Blue Chip Stock?
• Occidental Petroleum Pulls Back To The Sweet Spot
• Should You Take a Cruise in Royal Caribbean Stock?
• Is Target Stock Aiming For A Breakout In 2023?

Want to see what other hedge funds are holding MTAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MedTech Acquisition Co. (NASDAQ:MTAC – Get Rating).

Receive News & Ratings for MedTech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedTech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.